Perceptive Advisors’s Forte Biosciences FBRX Stock Holding History

Perceptive Advisors’s Portfolio FBRX Stock Details FBRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-68,192	Closed	-$882K	–	97
2025 Q2	$882K	Buy	+68,192	New	+$587K	0.03%	77
2025 Q1	–	Sell	-95,742	Closed	-$2.17M	–	94
2024 Q4	$2.17M	Hold	95,742	–	–	0.06%	85
2024 Q3	$535K	Sell	95,742 -34,872	-27%	-$359K	0.01%	103
2024 Q2	$1.75M	Hold	130,614	–	–	0.04%	95
2024 Q1	$2.27M	Hold	130,614	–	–	0.04%	103
2023 Q4	$2.68M	Hold	130,614	–	–	0.06%	85
2023 Q3	$2.16M	Buy	+130,614	New	+$2.9M	0.07%	83
2021 Q3	–	Sell	-27,400	Closed	-$23M	–	148
2021 Q2	$23M	Hold	27,400	–	–	0.3%	79
2021 Q1	$23.5M	Buy	27,400 +13,400	+96%	+$11M	0.3%	73
2020 Q4	$12.7M	Buy	+14,000	New	+$13.2M	0.14%	100

Other funds holding FBRX

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

TCM

Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Perceptive Advisors's FBRX Position: Q3 2025 in Review

Perceptive Advisors sold out of Forte Biosciences (FBRX) in Q3 2025, closing a stake of 68,192 shares — an estimated $882K sold.

Perceptive Advisors first reported a position in FBRX in Q4 2020 and held it in 10 quarters. The position peaked at $23.5M in Q1 2021. 42 funds tracked by Wall St. Rank hold FBRX as of Q3 2025.

Perceptive Advisors reported no remaining Forte Biosciences position as of Q3 2025 after selling out during the quarter.
Perceptive Advisors sold 68,192 Forte Biosciences shares in Q3 2025, an estimated $882K.
Perceptive Advisors first reported a position in Forte Biosciences in Q4 2020 and held it in 10 quarters.
Perceptive Advisors's Forte Biosciences position peaked at $23.5M in Q1 2021.
42 funds tracked by Wall St. Rank held Forte Biosciences as of Q3 2025.

Based on Perceptive Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.